IE36995B1 - Improvements in and relating to attenuated viruses - Google Patents

Improvements in and relating to attenuated viruses

Info

Publication number
IE36995B1
IE36995B1 IE1716/72A IE171672A IE36995B1 IE 36995 B1 IE36995 B1 IE 36995B1 IE 1716/72 A IE1716/72 A IE 1716/72A IE 171672 A IE171672 A IE 171672A IE 36995 B1 IE36995 B1 IE 36995B1
Authority
IE
Ireland
Prior art keywords
virus
attenuated
cattle
dec
diluent
Prior art date
Application number
IE1716/72A
Other languages
English (en)
Other versions
IE36995L (en
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of IE36995L publication Critical patent/IE36995L/xx
Publication of IE36995B1 publication Critical patent/IE36995B1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/76—Viruses; Subviral particles; Bacteriophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16732—Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation
    • C12N2710/16764—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IE1716/72A 1971-12-10 1972-12-08 Improvements in and relating to attenuated viruses IE36995B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2161344A DE2161344C3 (de) 1971-12-10 1971-12-10 Herstellung von Virusstämmen, welche die natürlichen Abwehrmechanismen eines Wirtsorganismus stimulieren, ohne dabei gleichzeitig antigen zu wirken und Arzneimittel zur Prophylaxe und Behandlung von viralen und bakteriellen Infektionen des Menschen und der Tiere, einen solchen Virusstamm enthaltend

Publications (2)

Publication Number Publication Date
IE36995L IE36995L (en) 1973-06-10
IE36995B1 true IE36995B1 (en) 1977-04-13

Family

ID=5827622

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1716/72A IE36995B1 (en) 1971-12-10 1972-12-08 Improvements in and relating to attenuated viruses

Country Status (22)

Country Link
JP (2) JPS6011013B2 (enExample)
AR (1) AR204075A1 (enExample)
AT (1) AT326817B (enExample)
AU (1) AU473209B2 (enExample)
BE (1) BE792484A (enExample)
BG (1) BG21417A3 (enExample)
CA (1) CA988848A (enExample)
CH (1) CH577558A5 (enExample)
CS (1) CS189587B2 (enExample)
DD (1) DD108115A5 (enExample)
DE (1) DE2161344C3 (enExample)
DK (1) DK143201C (enExample)
ES (1) ES409464A1 (enExample)
FR (1) FR2162637B1 (enExample)
GB (1) GB1356076A (enExample)
HU (1) HU167086B (enExample)
IE (1) IE36995B1 (enExample)
NL (1) NL178014C (enExample)
PH (1) PH12597A (enExample)
SE (1) SE8400283L (enExample)
SU (1) SU439956A3 (enExample)
ZA (1) ZA728709B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0063657A1 (en) * 1981-04-29 1982-11-03 Merck & Co. Inc. Topical application of interferon inducers

Also Published As

Publication number Publication date
JPS5924137B2 (ja) 1984-06-07
GB1356076A (en) 1974-06-12
ES409464A1 (es) 1976-03-16
DE2161344C3 (de) 1986-10-02
AU4992072A (en) 1974-06-13
ZA728709B (en) 1973-08-29
AR204075A1 (es) 1975-11-20
JPS4862919A (enExample) 1973-09-01
AU473209B2 (en) 1976-06-17
CS189587B2 (en) 1979-04-30
DD108115A5 (enExample) 1974-09-05
PH12597A (en) 1979-06-27
BG21417A3 (bg) 1976-05-20
ATA1041972A (de) 1975-03-15
CH577558A5 (enExample) 1976-07-15
SE8400283D0 (sv) 1984-01-20
BE792484A (fr) 1973-06-08
NL7216628A (enExample) 1973-06-13
DK143201C (da) 1981-12-14
DK143201B (da) 1981-07-20
NL178014C (nl) 1986-01-02
IE36995L (en) 1973-06-10
AT326817B (de) 1975-12-29
HU167086B (enExample) 1975-08-28
SE8400283L (sv) 1984-01-20
SU439956A3 (ru) 1974-08-15
JPS4862912A (enExample) 1973-09-01
JPS6011013B2 (ja) 1985-03-22
CA988848A (en) 1976-05-11
FR2162637B1 (enExample) 1976-07-02
DE2161344A1 (de) 1973-06-20
NL178014B (nl) 1985-08-01
FR2162637A1 (enExample) 1973-07-20
DE2161344B2 (de) 1980-05-08

Similar Documents

Publication Publication Date Title
Levy-Koenig et al. Immunology of Interferons: II. Heterospecific Activities of Human Interferons and Their Neutralization by Antibody
GB1382607A (en) Thixotropic composition
IE36995L (en) Producing attenuated viruses.
GB1169930A (en) Improvements in or relating to Lactam Salts
GB913904A (en) Pipe coupling
GB1444968A (en) Manufacture of t-butanol
GB899205A (en) The purification and polymerisation of vinylene carbonate
GB680788A (en) Pharmaceutical products
USD134664S (en) Combination bottle cap opener and bricklayer s line pin
Kozikowski et al. Interferon induction by the psittacosis agent in guinea pig leukocyte cultures
USD207191S (en) Display stand for jars or the like
GB1413401A (en) Influenza vaccine
USD140747S (en) Glass candle holder or article of similar nature
GB1391772A (en) Polymerisation process
FR914535A (fr) Procédé de préparation des interpolymères d'éthylène avec les esters vinyliques et produits en résultant
Hirsch et al. A new Salmonella type: Salmonella emek
USD201260S (en) Figure
GB1444980A (en) Psychotropic medicinal preparation
USD134181S (en) Design for a bottle or similar article
USD130688S (en) Design for a cooking range
USD201582S (en) Figure
GB1390650A (en) Oxazines and thiazines
USD204701S (en) Figure
ES347230A1 (es) Procedimiento para preparar carbonatos de 3-oxo - 17-beta- hidroxiestra-4, 9, 11-trieno.
GB942868A (en) Preparing triethylenediamine